{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:06Z","timestamp":1791308826174,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.toxicon.2006.02.013","type":"journal-article","created":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T12:16:57Z","timestamp":1143289017000},"page":"877-884","source":"Crossref","is-referenced-by-count":37,"title":["Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey"],"prefix":"10.1016","volume":"47","author":[{"given":"James","family":"Boles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Tammariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Louise M.","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross D.","family":"LeClaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.toxicon.2006.02.013_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1083\/jcb.103.2.521","article-title":"Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves","volume":"103","author":"Black","year":"1986","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.toxicon.2006.02.013_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1083\/jcb.103.2.535","article-title":"Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis","volume":"103","author":"Black","year":"1986","journal-title":"J. Cell Biol."},{"issue":"9\/10","key":"10.1016\/j.toxicon.2006.02.013_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.toxicon.2006.02.013_bib4","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.toxicon.2006.02.013_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr. Purif."},{"issue":"8","key":"10.1016\/j.toxicon.2006.02.013_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.toxicon.2006.02.013_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/plas.1997.1329","article-title":"Genetically engineered vaccines: an overview","volume":"39","author":"Dertzbaugh","year":"1998","journal-title":"Plasmid"},{"issue":"16","key":"10.1016\/j.toxicon.2006.02.013_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(96)00094-1","article-title":"Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum","volume":"14","author":"Dertzbaugh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.toxicon.2006.02.013_bib9","series-title":"Clostridium botulinum\u2013Ecology and Control in Foods","first-page":"3","article-title":"Clostridium botulinum and other clostridia that produce botulinum neurotoxins","author":"Hatheway","year":"1992"},{"key":"10.1016\/j.toxicon.2006.02.013_bib10","series-title":"Therapy with Botulinum","first-page":"93","article-title":"Immunogencity of the Neurotoxins of Clostridium Botulinum","author":"Hatheway","year":"1994"},{"issue":"2\/3","key":"10.1016\/j.toxicon.2006.02.013_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0264-410X(00)00155-9","article-title":"Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin","volume":"19","author":"Holley","year":"2000","journal-title":"Vaccine"},{"issue":"3378","key":"10.1016\/j.toxicon.2006.02.013_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.130.3378.763","article-title":"The most poisonous posion","volume":"130","author":"Lamanna","year":"1959","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.toxicon.2006.02.013_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1045-1056(02)00074-X","article-title":"Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primates","volume":"31","author":"Lindsey","year":"2003","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.toxicon.2006.02.013_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0014-5793(94)00449-8","article-title":"Bacterial protein toxins penetrate cells via a four-step mechanism","volume":"346","author":"Montecucco","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2006.02.013_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/978-3-642-61105-6_32","article-title":"The mechanism of action of tetanus and botulinum neurotoxins","volume":"18","author":"Montecucco","year":"1996","journal-title":"Arch. Toxicol. Suppl."},{"issue":"7\/8","key":"10.1016\/j.toxicon.2006.02.013_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0264-410X(99)00264-9","article-title":"The immunogenicity in humans of a botulinum type F vaccine","volume":"18","author":"Montgomery","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.toxicon.2006.02.013_bib17","series-title":"National Academy of Sciences","article-title":"Guide to the care and use of laboratory animals","year":"1996"},{"issue":"3","key":"10.1016\/j.toxicon.2006.02.013_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/prep.1998.0910","article-title":"Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris","volume":"13","author":"Potter","year":"1998","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.toxicon.2006.02.013_bib19","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"issue":"11","key":"10.1016\/j.toxicon.2006.02.013_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum neurotoxin","volume":"36","author":"Smith","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2006.02.013_bib21","series-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","first-page":"427","article-title":"Vaccines for preventing botulism","author":"Smith","year":"2002"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010106000961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010106000961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T10:34:23Z","timestamp":1586774063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010106000961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0041010106000961"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2006.02.013","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}